Urologix, Inc. (ULGX) Reports Q4 Loss of $0.17/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Urologix, Inc. (ULGX) Reports Q4 Loss of $0.17/Share

Urologix Reports Fourth Quarter and Fiscal Year 2014 Results

August 19, 2014 4:00 PM EDT

Recent Highlights

Urologix restructured the company in April 2014 which reduced cash utilization in the fourth quarter to $98,000 Cost-effectiveness data covering Cooled ThermoTherapyTM presented at 2014 AUA Annual Meeting in May

MINNEAPOLIS, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB: ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today reported financial results for its fourth quarter and fiscal year ended June 30, 2014. The Company also announces that Brian Smrdel, Chief Financial Officer, resigned due to personal reasons effective August 13, 2014.... More